Citation Impact
Citing Papers
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis
2004
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
1993
Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis
2009
Osteoporosis
2019 Standout
Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis
1990
Thyroid cancer
2016 Standout
Discontinuous calcitonin treatment of established osteoporosis—effects of withdrawal of treatment
1990
Bone mineral density measured by dual-energy X-ray absorptiometry in healthy finnish women
1991
The Role of Calcitonin in the Development and Treatment of Osteoporosis*
1987
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change
2003 Standout
Assessing the Impact of Osteoporosis on the Burden of Hip Fractures
2012
VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis
2002
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
1993 Standout
Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome
1992
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Osteoporosis: now and the future
2011 Standout
Effect of calcitonin on bone mass and fracture rates
1991
Biochemical and hormonal variables in black and white women matched for age and weight
1998
Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus.
1995
Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation
1998
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Suppression of bone formation by osteoclastic expression of semaphorin 4D
2011 Standout
Epidemiology of stone disease across the world
2017 Standout
Osteoporosis after solid organ and bone marrow transplantation
2003
Osteoporosis: burden, health care provision and opportunities in the EU
2011
Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women
1997
Bisphosphonate treatment of osteoporosis
2003
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Theoretical perspective: A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates
1996
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: A multicenter longitudinal study
2011
Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: A randomized controlled trial
1995
Italian guidelines for the diagnosis and treatment of Paget’s disease of bone
2011
Primary Biliary Cirrhosis
2011 Standout
Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
2000
Parenteral Calcitonin for Metabolic Bone Disease Associated With Primary Biliary Cirrhosis
1994
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Vitamin D and Immune Function
2013 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
The Role of Vitamin D in Cancer Prevention
2005 Standout
High-Dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse
1993
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
1996
Cancer treatment and survivorship statistics, 2019
2019 Standout
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Estrogen-induced osteogenesis in intact female mice lacking ERβ
2002 StandoutNobel
Kidney Stone Disease: An Update on Current Concepts
2018 Standout
Guidelines for the management of thyroid cancer
2014 Standout
Kidney stones: an update on current pharmacological management and future directions
2013
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus.
2006
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Calcitonin treatment and plasma prolactin levels in pregnant and lactating ewes
1984
Population-Based Study of Age and Sex Differences in Bone Volumetric Density, Size, Geometry, and Structure at Different Skeletal Sites
2004 Standout
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of E Palummeri being referenced
Meal-stimulated gastrin release and calcitonin secretion
1989
Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS)
2003
The comparative effect of ovarian hormone administration on bone mineral status in oophorectomized rats
1989
Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis
1991
Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments
2008
High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture
2006
The pathophysiology of calcitonin in man.
1986
Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study
1986
Short-term intravenous therapy with Neridronate in Paget's disease.
2002
Calcitonin deficit syndrome in thyroidectomized patients.
1985
[Changes in bone mass with age. Transversal study on a female population using photon densitometry].
1987
Does calcitonin modulate anterior pituitary hormone secretion?
1982
Osteocalcin levels in diabetic subjects
1989